This grant funds research projects focused on developing new animal drugs intended for minor uses in major species or for use in minor species. It supports costs related to qualified safety and effectiveness testing necessary for FDA approval of MUMS-designated drugs. Applicants must have FDA minor use/minor species designation, an open INAD file, and FDA concurrence on study protocols. Eligible applicants include veterinary drug developers and their research partners.
Eligible applicants include a wide range of organizations such as public housing authorities, for-profit organizations, nonprofits, small businesses, tribal governments, educational institutions, and foreign entities. Applicants must be developing veterinary drugs or research partners and hold FDA m
